Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $5.03 and traded as high as $6.86. Tenax Therapeutics shares last traded at $6.75, with a volume of 33,111 shares trading hands.
Tenax Therapeutics Price Performance
The firm’s fifty day moving average price is $6.38 and its 200-day moving average price is $5.04.
Hedge Funds Weigh In On Tenax Therapeutics
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TENX. Two Sigma Investments LP acquired a new position in Tenax Therapeutics in the 4th quarter worth $84,000. Sphera Funds Management LTD. acquired a new position in Tenax Therapeutics in the 3rd quarter worth $101,000. Geode Capital Management LLC boosted its stake in Tenax Therapeutics by 32.4% in the 4th quarter. Geode Capital Management LLC now owns 24,354 shares of the specialty pharmaceutical company’s stock worth $151,000 after purchasing an additional 5,964 shares during the period. Millennium Management LLC acquired a new position in Tenax Therapeutics in the 4th quarter worth $166,000. Finally, Stonepine Capital Management LLC acquired a new position in Tenax Therapeutics in the 3rd quarter worth $173,000. 1.67% of the stock is owned by institutional investors and hedge funds.
About Tenax Therapeutics
Tenax Therapeutics, Inc develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.
Read More
- Five stocks we like better than Tenax Therapeutics
- Bank Stocks – Best Bank Stocks to Invest In
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Profitably Trade Stocks at 52-Week Highs
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Tenax Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenax Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
